A scientific perspective of how and why Omicron is less severe than SARS-CoV-2
Abstract. Omicron is currently the dominant variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus responsible for the coronavirus disease 2019 (COVID-19) pandemic. Omicron is associated with mild symptoms, although it can cause harmful effects in high-risk patient...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health/LWW
2023-09-01
|
| Series: | Emergency and Critical Care Medicine |
| Online Access: | http://journals.lww.com/10.1097/EC9.0000000000000092 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850151607139827712 |
|---|---|
| author | Rachel Parise Sindhu Ramesh Jun Ren Manoj Y. Govindarajulu Rishi M. Nadar Suhrud Pathak Timothy Moore Muralikrishnan Dhanasekaran |
| author_facet | Rachel Parise Sindhu Ramesh Jun Ren Manoj Y. Govindarajulu Rishi M. Nadar Suhrud Pathak Timothy Moore Muralikrishnan Dhanasekaran |
| author_sort | Rachel Parise |
| collection | DOAJ |
| description | Abstract. Omicron is currently the dominant variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus responsible for the coronavirus disease 2019 (COVID-19) pandemic. Omicron is associated with mild symptoms, although it can cause harmful effects in high-risk patient populations. Omicron and COVID-19 affect multiple organ systems, including the respiratory system, gastrointestinal tract, cardiovascular system, central nervous system, ophthalmic system, genitourinary tract, and musculoskeletal system. COVID-19 infects additional organ systems, including the hematological system, hepatobiliary system, renal system, and dermatologic system. The viral-induced complications were compared to discuss the effects of Omicron versus the authentic SARS-CoV-2 virus, revealing less detrimental outcomes for Omicron. Moreover, COVID-19 is more likely to infect older adults, males, and obesity with mild to severe symptoms. Omicron causes mild symptoms in younger populations and overweight females. Data were acquired using PubMed, Centers for Disease Prevention and Control, and the World Health Organization. COVID-19 and Omicron mechanisms causing organ system-related complications are likely because of the natural immune response to the active infection, the uncontrollable release of cytokines causing cytokine release syndrome, and direct viral damage through angiotensin-converting enzyme 2/transmembrane serine protease 2 receptor binding and entrance to the host cell for infection. |
| format | Article |
| id | doaj-art-a7edfa7eb8d34d11a628ad06508eefe9 |
| institution | OA Journals |
| issn | 2097-0617 2693-860X |
| language | English |
| publishDate | 2023-09-01 |
| publisher | Wolters Kluwer Health/LWW |
| record_format | Article |
| series | Emergency and Critical Care Medicine |
| spelling | doaj-art-a7edfa7eb8d34d11a628ad06508eefe92025-08-20T02:26:10ZengWolters Kluwer Health/LWWEmergency and Critical Care Medicine2097-06172693-860X2023-09-013311512110.1097/EC9.0000000000000092202309000-00005A scientific perspective of how and why Omicron is less severe than SARS-CoV-2Rachel Parise0Sindhu Ramesh1Jun Ren2Manoj Y. Govindarajulu3Rishi M. Nadar4Suhrud Pathak5Timothy Moore6Muralikrishnan Dhanasekaran7a Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL, USAa Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL, USAb Department of Cardiology, Zhongshan Hospital Fudan University, Shanghai, Chinaa Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL, USAa Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL, USAa Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL, USAa Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL, USAa Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL, USAAbstract. Omicron is currently the dominant variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus responsible for the coronavirus disease 2019 (COVID-19) pandemic. Omicron is associated with mild symptoms, although it can cause harmful effects in high-risk patient populations. Omicron and COVID-19 affect multiple organ systems, including the respiratory system, gastrointestinal tract, cardiovascular system, central nervous system, ophthalmic system, genitourinary tract, and musculoskeletal system. COVID-19 infects additional organ systems, including the hematological system, hepatobiliary system, renal system, and dermatologic system. The viral-induced complications were compared to discuss the effects of Omicron versus the authentic SARS-CoV-2 virus, revealing less detrimental outcomes for Omicron. Moreover, COVID-19 is more likely to infect older adults, males, and obesity with mild to severe symptoms. Omicron causes mild symptoms in younger populations and overweight females. Data were acquired using PubMed, Centers for Disease Prevention and Control, and the World Health Organization. COVID-19 and Omicron mechanisms causing organ system-related complications are likely because of the natural immune response to the active infection, the uncontrollable release of cytokines causing cytokine release syndrome, and direct viral damage through angiotensin-converting enzyme 2/transmembrane serine protease 2 receptor binding and entrance to the host cell for infection.http://journals.lww.com/10.1097/EC9.0000000000000092 |
| spellingShingle | Rachel Parise Sindhu Ramesh Jun Ren Manoj Y. Govindarajulu Rishi M. Nadar Suhrud Pathak Timothy Moore Muralikrishnan Dhanasekaran A scientific perspective of how and why Omicron is less severe than SARS-CoV-2 Emergency and Critical Care Medicine |
| title | A scientific perspective of how and why Omicron is less severe than SARS-CoV-2 |
| title_full | A scientific perspective of how and why Omicron is less severe than SARS-CoV-2 |
| title_fullStr | A scientific perspective of how and why Omicron is less severe than SARS-CoV-2 |
| title_full_unstemmed | A scientific perspective of how and why Omicron is less severe than SARS-CoV-2 |
| title_short | A scientific perspective of how and why Omicron is less severe than SARS-CoV-2 |
| title_sort | scientific perspective of how and why omicron is less severe than sars cov 2 |
| url | http://journals.lww.com/10.1097/EC9.0000000000000092 |
| work_keys_str_mv | AT rachelparise ascientificperspectiveofhowandwhyomicronislessseverethansarscov2 AT sindhuramesh ascientificperspectiveofhowandwhyomicronislessseverethansarscov2 AT junren ascientificperspectiveofhowandwhyomicronislessseverethansarscov2 AT manojygovindarajulu ascientificperspectiveofhowandwhyomicronislessseverethansarscov2 AT rishimnadar ascientificperspectiveofhowandwhyomicronislessseverethansarscov2 AT suhrudpathak ascientificperspectiveofhowandwhyomicronislessseverethansarscov2 AT timothymoore ascientificperspectiveofhowandwhyomicronislessseverethansarscov2 AT muralikrishnandhanasekaran ascientificperspectiveofhowandwhyomicronislessseverethansarscov2 AT rachelparise scientificperspectiveofhowandwhyomicronislessseverethansarscov2 AT sindhuramesh scientificperspectiveofhowandwhyomicronislessseverethansarscov2 AT junren scientificperspectiveofhowandwhyomicronislessseverethansarscov2 AT manojygovindarajulu scientificperspectiveofhowandwhyomicronislessseverethansarscov2 AT rishimnadar scientificperspectiveofhowandwhyomicronislessseverethansarscov2 AT suhrudpathak scientificperspectiveofhowandwhyomicronislessseverethansarscov2 AT timothymoore scientificperspectiveofhowandwhyomicronislessseverethansarscov2 AT muralikrishnandhanasekaran scientificperspectiveofhowandwhyomicronislessseverethansarscov2 |